Drug Profile
Peginterferon alfa-2a - Dong-A
Alternative Names: DA-3021Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Dong-A Pharmaceutical
- Class Antineoplastics; Antivirals; Interferons; Polyethylene glycols
- Mechanism of Action Immunostimulants; Interferon alfa 2a stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis B; Hepatitis C
Most Recent Events
- 15 Dec 2010 No development reported - Phase-I for Hepatitis B in South Korea (SC)
- 15 Dec 2010 No development reported - Phase-I for Hepatitis C in South Korea (SC)
- 14 Jan 2009 Phase-I clinical trials in Hepatitis B in South Korea (SC)